Business

July 21, 2014

Proteon Therapeutics’ hemodialysis drug tests advance

The biopharmaceutical company founded in the Kansas City area has begun Phase 3 clinical testing of its drug designed to improve care of chronic kidney disease patients.

Related content

Comments

Videos

Editor's Choice Videos